A Drug-Loaded Aptamer−Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer

Author:

Kim Dongkyu1,Jeong Yong Yeon2,Jon Sangyong1

Affiliation:

1. Cell Dynamics Research Center, Research Center for Biomolecular Nanotechnology, School of Life Sciences, Gwangju Institute of Science and Technology, 261 Chemdan-gwagiro, Gwangju 500-712, Republic of Korea

2. Department of Diagnostic Radiology, Chonnam National University Hwasun Hospital, 160 Ilsim-ri, Hwasun-eup, Jeonnam 519-809, Republic of Korea

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Cited by 640 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Targeting the prostate tumor microenvironment by plant-derived natural products;Cellular Signalling;2024-03

2. Nanotherapeutics for prostate cancer treatment: A comprehensive review;Biomaterials;2024-03

3. Targeting strategies using gold nanoparticles for efficient drug delivery;Gold Nanoparticles for Drug Delivery;2024

4. Technological evolution in cancer diagnosis and therapeutics;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Nanocarrier-mediated delivery for targeting for prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3